PMVP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
PMV Pharmaceuticals Inc (PMVP) is not a good buy for a beginner investor with a long-term strategy at this time. The company's financials are weak, with declining net income and EPS, and no revenue growth. Analysts have significantly lowered the price target, and the stock's trend indicates a likelihood of further decline in the short to medium term. While hedge funds are buying, there are no strong positive catalysts or technical signals to justify an immediate investment.
The technical indicators show mixed signals. The MACD is positive but contracting, RSI is neutral, and moving averages are bullish. However, the stock's candlestick pattern suggests a 50% chance of a decline in the next day (-0.11%), week (-4.06%), and month (-4.93%). Key support is at 1.319, and resistance is at 1.495.
Hedge funds are significantly increasing their buying activity, with a 2450.33% increase over the last quarter.
Analysts have drastically reduced the price target from $16 to $4, reflecting a lack of confidence in the stock's future performance. Financial performance is weak, with no revenue growth and worsening net income and EPS. No recent news or Congress trading data to support the stock.
In 2025/Q4, the company reported no revenue growth (0% YoY), a net income drop of -21.58% YoY to -$18,037,000, and an EPS decline of -22.73% YoY to -0.34. Gross margin remains at 0%.
Evercore ISI lowered the price target to $4 from $16 while maintaining an Outperform rating. This reflects a significant downgrade in expectations for the stock.
